1. Glycosylation changes in inflammatory diseases
   Sophie Groux-Degroote et al, 2020, Inflammatory Disorders, Part A CrossRef
2. MiR-1202 Exerts Neuroprotective Effects on OGD/R Induced Inflammation in HM Cell by Negatively Regulating Rab1a Involved in TLR4/NF-κB Signaling Pathway
   Shuhuan Song et al, 2020, Neurochemical Research CrossRef
3. Upregulation of miRNA‑140‑5p inhibits inflammatory cytokines in acute lung injury through the MyD88/NF‑κB signaling pathway by targeting TLR4
   Ye Yang et al, 2018, Experimental and Therapeutic Medicine CrossRef
4. MicroRNA-541-5p REgulates Type II Alveolar Epithelial Cell Proliferation and Activity by Modulating the HMGB1 Expression
   Jie Shen et al, 2022, Shock CrossRef
5. Knockdown of versican 1 in lung fibroblasts aggravates Lipopolysaccharide-induced acute inflammation through up-regulation of the SP1-Toll-like Receptor 2-NF-κB Axis: a potential barrier to promising Versican-targeted therapy
   Lulu Xu et al, 2023, International Immunopharmacology CrossRef
6. VCAN activates JAK/STAT signaling pathway to promote the progression of LPS-induced acute pneumonia
   Yuqin He et al, 2023, Molecular & Cellular Toxicology CrossRef
7. TLR4/NF-κB signaling pathway gene single nucleotide polymorphisms alter gene expression levels and affect ARDS occurrence and prognosis outcomes
   Yueping Ding et al, 2019, Medicine CrossRef
8. Glycyrrhizin inactivates toll‐like receptor (TLR) signaling pathway to reduce lipopolysaccharide‐induced acute lung injury by inhibiting TLR2
   Delei Kong et al, 2019, Journal of Cellular Physiology CrossRef
9. Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1ß, and TNF-α, and the TLR4/TLR2/NF-κB/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells
   Juan Wu et al, 2019, PLOS ONE CrossRef
10. Versican is produced by Trif- and type I interferon-dependent signaling in macrophages and contributes to fine control of innate immunity in lungs
    Mary Y. Chang et al, 2017, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
11. Akkermansia muciniphila attenuated lipopolysaccharide-induced acute lung injury by modulating the gut microbiota and SCFAs in mice
    Jian Shen et al, 2023, Food & Function CrossRef
12. Versican: A Dynamic Regulator of the Extracellular Matrix
    Shamima Islam et al, 2020, Journal of Histochemistry & Cytochemistry CrossRef
13. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury
    Lingling Dai et al, 2018, Connective Tissue Research CrossRef
14. RETRACTED: MicroRNA-326 aggravates acute lung injury in septic shock by mediating the NF-κB signaling pathway
    Chun-Ting Wu et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
15. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3
    Xiaomeng Yi et al, 2019, Experimental Cell Research CrossRef
16. Versican—A Critical Extracellular Matrix Regulator of Immunity and Inflammation
    Thomas N. Wight et al, 2020, Frontiers in Immunology CrossRef
17. Silencing of lncRNA MIAT alleviates LPS-induced pneumonia via regulating miR-147a/NKAP/NF-κB axis
    Min Liu et al, 2021, Aging CrossRef
18. PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy
    Julia M. DeRogatis et al, 2021, Frontiers in Immunology CrossRef
19. Sodium butyrate alleviates LPS ‐induced kidney injury via inhibiting TLR2 /4 to regulate rBD2 expression
    Xiujing Dou et al, 2022, Journal of Food Biochemistry CrossRef
20. Lactobacillus reuteri Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the Gut Microbiota in Mice
    Jian Shen et al, 2023, Nutrients CrossRef
21. Interplay of extracellular matrix and leukocytes in lung inflammation
    Thomas N. Wight et al, 2017, Cellular Immunology CrossRef